Microcap defence stocks: capex and FY27 growth talk

Microcap defence stocks have become a frequent topic on Reddit and market social feeds, mainly because investors are comparing management guidance, order inflow visibility, and capex-led scaling plans. The discussion is not limited to one company, but a cluster of smaller listed names that are either in defence manufacturing, defence electronics, or precision engineering with defence exposure. A repeated angle is whether the next two years bring a step-up in revenue, supported by programs and negotiated orders. Another is whether margins can hold up while companies scale. The tone of posts is largely numbers-led: order book size, expected order inflows, and explicit FY27 growth guidance. Investors are also juxtaposing these microcap narratives against the broader sector outlook for India’s defence market, which is cited online as growing from USD 30,500 million in 2025 to USD 48,300 million by 2032 at a 6.78% CAGR. That macro growth point is often used to frame why smaller suppliers could see sustained tender activity. Still, the details investors are debating are company-specific and execution-heavy.

Apollo Micro Systems: FY26 base draws attention

Apollo Micro Systems is one of the most discussed names in the current thread because participants are anchoring the debate to its latest full-year base. As shared in the trending notes, Apollo Micro Systems reported revenue of Rs 904 crore, EBITDA of Rs 218 crore and profit after tax of Rs 107 crore in FY26. Those figures are being used to assess how steep the next leg of growth could be. Broker commentary circulating online adds a forward lens. ICICI Direct estimates revenue to grow at a 62% CAGR from FY26 to FY28E to Rs 2,378 crore. The same estimate set projects EBITDA rising at a 64% CAGR to Rs 587 crore, while profit after tax grows at a 71% CAGR to Rs 313 crore. Social posts are treating these estimates as a benchmark for what “execution” would look like. The discussion also highlights that the implied scale-up is large relative to the FY26 base. That is why order inflows and program share assumptions are being scrutinised closely.

Apollo order inflows: FY27 and the MIGM programme angle

On the order pipeline, the management expectation quoted in the social context is specific. Management expects Rs 2,500 crore to Rs 3,000 crore of additional order inflows during FY27. For a microcap stock narrative, that single line is shaping much of the debate. It is being read as an indicator of near-term booking momentum rather than a generic sector claim. Another key point being circulated is the MIGM programme opportunity. Management has indicated a potential roughly 70% share of the approximately Rs 3,500 crore MIGM programme. That translates to an opportunity of Rs 2,400 crore to Rs 2,500 crore, as shared in the notes. Market participants are discussing what portion of such opportunities convert into executable orders, and on what timelines. The MIGM share claim is also prompting comparisons with peers on programme participation. In investor threads, these program-linked opportunities are often treated separately from routine defence electronics and systems supply. The common thread is that visibility improves when a pipeline is tied to named programmes.

MTAR Technologies: FY27 guidance raised to 80% growth

MTAR Technologies is also being discussed heavily, partly because it is cited as part of the Nifty Microcap250 and has given a sharp guidance update. The trending context notes that MTAR Technologies achieved record fourth quarter (Q4FY26) sales of Rs 3,060 m and EBITDA of Rs 618 m with a net profit of about Rs 443 m. It also states that for FY26, standalone revenue stood at a record Rs 9,730 m, reflecting 25% YoY growth. The key social-media hook is not just the Q4 print, but the FY27 outlook. In a recent conference call, management raised revenue guidance for FY27 from 50% revenue growth to 80% revenue growth, plus or minus 5%. The same guidance set mentions EBITDA margins of around 24% for the year. Investors are parsing that margin number because rapid growth phases can pressure margins if mix shifts or commissioning timelines slip. Posts also point out that such a large uplift in guidance tends to raise expectations for quarterly progression.

Where the Rs 250 crore capex reference is coming from

A recurring keyword in the discussion is “Rs 250 crore capex”, largely because one widely shared note references a Rs 2.5 bn allocation to aerospace, defence and semiconductor capacity. In the circulating context, Sansera has allocated Rs 2.5 bn to buildings and machinery for its aerospace, defence, and semiconductor division. The same note says the existing facility runs to 140,000 square feet and has revenue potential of about Rs 6 bn at full utilisation. For investors, this becomes a concrete way to map capex to potential revenue capacity, even if timelines are not explicitly provided in the snippet. Another data point being discussed is order momentum in that division. The unexecuted order backlog for the same division has reached Rs 57.5 bn, boosted by a major semiconductor win, as shared online. Separately, the June 2026 quarter is described as strong, with revenue rising to Rs 10.2 bn from Rs 7.7 bn and net profit rising 39% to Rs 866 m. Management expects high-teens revenue growth for FY27, with capex coming on stream from the third quarter.

Order book visibility is a central talking point

Beyond named company snippets, investors are also sharing order book snapshots to argue for multi-year visibility. One widely circulated set of numbers says a consolidated order book reached a record Rs 28.5 bn. In the same note, management reaffirmed 15% to 20% revenue growth guidance for FY27, alongside steady annual capex of Rs 400 million to Rs 50 m, as written in the shared context. Another shared order book reference says the order book stood at Rs 26.5 bn as of 30 June, including negotiated orders pending formal receipt. That is described as providing about 2.3 years of revenue visibility at current run rates. A separate management outlook in the same social stream mentions maintaining 20-25% revenue growth over the next two to three years, with EBITDA margins of around 35-40% in FY27. It also says the company invested around Rs 1850 m in capex over the past five years and plans an additional Rs 1500 m over the next two years. These figures are being used in threads to compare visibility quality, not just headline growth.

How some posts frame the addressable market and big programmes

A longer-form investor note being shared in the same discussion includes a total addressable market estimate through FY28. Management identifies a total addressable market of Rs 240-250 bn through FY28, diversified across radar programs (Rs 100-110 bn), turnkey projects (Rs 50-60 bn), special projects (Rs 20-30 bn), exports (Rs 15-20 bn), and missiles and telemetry (as listed in the excerpt). The same thread claims management confidence of getting about Rs 80bn to Rs 100bn worth of new orders and cumulative revenue booking of about Rs 75bn plus over the next four years. Separately, another post highlights the estimated value of three programmes as around Rs 90,000 crore for P-75I, Rs 30,000 crore for QRSAM, and more than Rs 33,000 crore for NGC. These numbers are not being treated as immediate revenue but as a backdrop for tender flow and supply-chain participation. For smaller listed suppliers, the market’s focus tends to be on what slice of those programmes is realistic. That is why explicit “share” claims, like the MIGM point, get outsized attention.

Peer snapshot: Astra Micro Systems appears in comparisons

Some users are also posting peer snapshots to compare valuations and balance sheet leverage. One table circulated under “Best Smallcap Defence Stocks” includes Astra Micro Systems with a CMP of Rs 1,648.6 and P/E of 87.1x. The table lists market cap at Rs 156,526 m and debt to equity at 0.2x for the current year. It also shows EV/EBIT of 25.6, RoE of 15.2% and RoCE of 23.7%, with dividend yield at 0.1%. While this is only one row in the shared snippet, it is being used in social threads as a reference point for how richly defence electronics can trade when growth visibility is perceived as high. Importantly, such snapshots do not answer whether growth will materialise, but they show where the market sometimes prices certainty. Investors are using it to ask whether smaller names can deliver enough to justify re-rating. Others use it to argue that execution risk should be discounted more heavily in microcaps.

What investors are watching next: targets, revisions, and profitability

The threads also show a clear pattern in what traders and long-term investors plan to track. First is whether companies meet their own stated targets, especially where management has a documented history of revising targets. One note cites that an earlier commitment to Rs 45 bn of revenue by FY27 appears to have been succeeded by a Rs 50 bn target for FY28 or FY29. Second is commissioning and capex ramp, because several snippets explicitly connect growth to capacity coming on stream. One shared line says the company plans to deploy Rs 1.8-1.9 bn during FY27 as capex, with Rs 1.91 bn already added to capital work in progress, signalling commissioning is months away. Third is profitability stability, because multiple guidance points cite margins like ~24% EBITDA margin and even 35-40% EBITDA margins in FY27 in certain cases. Finally, some posts flag non-operational impacts on profits. One regional-language snippet notes that foreign subsidy restructuring impacted profits to some extent, while the company currently has a standalone order book of Rs 16.45 bn. These are the kinds of details that can shape near-term sentiment even when order books look strong.

Bottom line: the debate is about conversion, not just opportunity

Across all these posts, the market conversation is less about whether India’s defence opportunity exists and more about who converts it fastest. Apollo Micro Systems is being tracked for FY27 inflow expectations of Rs 2,500-3,000 crore and the MIGM programme share commentary. MTAR Technologies is being watched for whether an 80% FY27 growth guidance and ~24% margin can be delivered across quarters. The Rs 250 crore capex theme is being anchored to the Rs 2.5 bn allocation referenced for aerospace, defence and semiconductor capacity and how that translates into utilisation and revenue. Order book visibility metrics like Rs 28.5 bn and Rs 26.5 bn are being used as shorthand for multi-year coverage, but investors still want clarity on delivery schedules. The broader defence market growth and the large programme values are acting as context rather than near-term triggers. For microcaps, the market’s tolerance for delays is usually low because expectations can change quickly. That is why these threads keep circling back to execution proof points, not just projections.